Evidence map›Paper›PMID 39830749›Full record

ArticleTranslational lung cancer research2024

Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis.

Shuangyan Yang, Bin Su, Hui Liu

Abstract read
In one paragraph

Article in Translational lung cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shuangyan Yang *Department of Radiation Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China.
Bin Su *Department of Radiation Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China.
Hui LiuDepartment of Radiation Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Stereotactic body radiation therapy (SBRT) is crucial for treating early-stage inoperable non-small cell lung cancer (NSCLC) due to its precision and high-dose delivery. This study aimed to investigate the dosimetric deviations in gated (GR) versus non-gated radiotherapy (NGR), analyzing the impact of tumor location, target volume, and tumor motion range on dose distribution accuracy. Methods: Sixty patients treated with either gated (n=30) or non-gated (n=30) SBRT for early-stage NSCLC were retrospectively analyzed. The planned dose distributions were determined using four-dimensional computed tomography simulations to account for breathing motion, while the actual dose delivered was determined by accumulating each fractional dose with synthetic computed tomography (sCT) methods. The deviations between the planned and actual accumulated doses were statistically analyzed for both groups. The effects of tumor location and volume on dose distribution were also assessed. Results: Gated SBRT showed significantly higher dosimetric precision with median relative changes in the minimum dose within the ITV (ITV_D Conclusions: Gated SBRT affords dosimetric accuracy compared to non-gated SBRT, and thus could improve the therapeutic outcomes of NSCLC patients. These results should advocate for the preferential use of gated SBRT in cases requiring precise dose delivery due to large respiratory motion or small target volumes.

Indexed as

gated radiotherapy (GR)non-small cell lung cancer (NSCLC)Stereotactic body radiation therapy (SBRT)synthetic computed tomography (sCT)

Identifiers

PMID39830749
PMCPMC11736606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.